Myriad Genetics logo

Myriad Genetics

MYGN | NASDAQ
Chart Builder DCF Calculator
$5.57
-$0.09 (-1.59%)
At close: Nov 16, 2026, 4:00 PM ET
$5.57
$0.00 (0.00%)
After-hours: Nov 16, 2026, 5:56 PM ET
-1.59%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
26.2
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #893/1021 (Top 87%)

Key Statistics

Market Data

Market Cap $534.29M
1D Range
5.48 5.65
52W Range
2.86 7.91

Valuation (TTM)

PE -4.10
PB 1.99
EV/EBITDA -8.50

Valuation (NTM)

Forward PE 36.09
Forward PEG 0.00
Price Target $5.00
Loading financial charts...

Profile

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomic...

Sector Healthcare
Employees 2,700
IPO Date Oct 6, 1995
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.11
Beat +44.88%
REV
$202.7M
Beat +5.94%
Next Earnings
Feb 22, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
7
Consensus
Hold
Price Target
$5.00
Downside
-10.23%
Buy (1)
Hold (5)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.